Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case?
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
As the Broad Institute faces a formidable task in defending its revoked CRISPR patent claims in a pending appeal at the EPO, European academics Jakob Wested, Timo Minssen, and Esther van Zimmeren are wondering whether some of the issues might be referred to the Enlarged Board of Appeal.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Life Sciences Intellectual Property Review (LSIPR) |
Udgave nummer | 13/7 2018 |
Antal sider | 6 |
Status | Udgivet - 13 jul. 2018 |
- Det Juridiske Fakultet
Forskningsområder
Links
- https://www.lifesciencesipreview.com/article/will-the-epo-s-enlarged-board-hear-the-broad-s-crispr-case
Forlagets udgivne version
ID: 199125991